Delivery Order SPE2DB22D2206-SPE2DB25FEC24

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,387.26 firm fixed-price delivery order is for the supply of Phenobarbital 65 mg/ml vials. The contract has a period of performance through November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,683.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, identified as SPE2DX15D1022|SPE2DX25FVEHS, is a delivery order contract for the supply of 4567951747 PHENOBARBITAL 130 MG/ML VIALML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,190.18, is a delivery order for the supply of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
This federal contract award, valued at $2,117.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Phenobarbital 130 mg/ml vials and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,296.66 firm fixed-price delivery order is for the procurement of 4567673577 ! PHENOBARBITAL 130 MG/ML VIALML, with a completion date of March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $2,190.18, is a delivery order for the supply of Phenobarbital 130 mg/ml vials. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2025. This award is not associated with a set-aside program and appears to be part of a...
This federal contract award, valued at $2,960.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 65 mg/mL vials, a medication used for various medical conditions. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,561.94 firm-fixed-price delivery order is for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,027.94 Firm Fixed Price Delivery Order (SPE2DX15D1022|SPE2DX23FVGVL) is for the supply of Phenobarbital 130 mg/ml vials. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as...
This federal contract award is a delivery order valued at $5,149.68 issued to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4566516943 - Phenobarbital 130 mg/ml vials. Amerisourcebergen is the prime contractor and a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of medical commodities, including specialty medications,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEC24
    Delivery Order

This federal contract award, valued at $2,457.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PHENOBARBITAL 65 MG/ML VIALML. The award has an ultimate completion date of November 6, 2024 and is a firm fixed-price contract.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/4/25, 10:40 AM